E72.01 Cystinuria

Name of the Condition

• Cystinuria (ICD-10 Code: E72.01)

Summary

Cystinuria is a genetic disorder characterized by the impaired reabsorption of certain amino acids, including cystine, in the kidneys. This leads to excessive cystine excretion in the urine, which can form crystals and stones in the urinary tract. The condition primarily affects the kidneys and urinary system, with potential for recurrent stone formation and associated complications.

Causes

Cystinuria is caused by mutations in the SLC3A1 or SLC7A9 genes, which encode proteins involved in amino acid transport in the renal tubules. These mutations disrupt the normal reabsorption of cystine and other dibasic amino acids, leading to their accumulation in the urine. The disorder is inherited in an autosomal recessive pattern, requiring two mutated gene copies to manifest.

Risk Factors

• Family history of cystinuria or kidney stones.
• Consanguinity (parents who are close relatives) increasing recessive inheritance risk.
• Ethnic or geographic prevalence of specific genetic variants in certain populations.

Symptoms

• Recurrent kidney stones, often causing pain in the back, side, or groin.
• Hematuria (blood in urine) due to stone irritation.
• Urinary tract infections (UTIs) or obstruction.
• Nausea, vomiting, or fever if stones cause blockage or infection.

Diagnosis

Diagnosis involves urine tests to detect elevated cystine levels, imaging studies (e.g., CT scans or X-rays) to identify stones, and genetic testing to confirm mutations in the SLC3A1 or SLC7A9 genes. Family screening may also be recommended due to the hereditary nature of the condition.

Treatment Options

• Increased fluid intake to dilute urine and prevent stone formation.
• Alkalinizing agents (e.g., potassium citrate) to reduce cystine crystallization.
• Medications like tiopronin to bind cystine and prevent stone growth.
• Surgical or procedural interventions (e.g., lithotripsy) to remove or break up existing stones.

Prognosis and Follow-Up

With proper management, including hydration and medication, prognosis is generally good, though recurrent stones may occur. Regular follow-up with a healthcare provider is essential to monitor kidney function, adjust treatment, and address complications. Long-term outcomes depend on adherence to preventive measures and timely intervention for stone-related issues.

Complications

• Chronic kidney disease or renal damage from recurrent stones.
• Urinary tract obstruction leading to infection or impaired kidney function.
• Increased risk of kidney stone recurrence without ongoing management.

Lifestyle & Prevention

• Maintain high fluid intake (2-3 liters daily) to keep urine dilute.
• Follow a low-sodium, moderate-protein diet to reduce cystine excretion.
• Avoid excessive vitamin C or certain supplements that may increase stone risk.
• Monitor urine pH and cystine levels as advised by a healthcare provider.

When to Seek Professional Help

• Severe or persistent pain in the back, side, or groin.
• Blood in urine, fever, chills, or nausea/vomiting.
• Difficulty urinating or signs of urinary tract obstruction.
• Recurrent stones despite preventive measures.

Tips for Medical Coders

When coding for cystinuria (E72.01), ensure documentation supports the diagnosis, including clinical findings (e.g., stone formation, urinary symptoms) and genetic testing results if available. Verify that the code is used for confirmed cases and not for asymptomatic carriers or related conditions. Documentation should reflect the specific amino acid transport defect and any associated complications to support accurate coding.